#Coronary Stent Market Research

[amrutatbrc1]

Bifurcation Lesions Market 2024-2033 : Demand, Trend, Segmentation, Forecast, Overview And Top Companies 

The bifurcation lesions global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Bifurcation Lesions Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size - The bifurcation lesions market size has grown strongly in recent years. It will grow from $2.47 billion in 2023 to $2.7 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to rise in prevalence of coronary artery diseases, rise in geriatric population, rise in healthcare expenditure, economic growth.

The bifurcation lesions market size is expected to see strong growth in the next few years. It will grow to $3.74 billion in 2028 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing demand for minimally invasive surgeries, expansion of healthcare infrastructure and facilities, increasing prevalence of cardiovascular diseases, government healthcare policies. Major trends in the forecast period include patient-centric approaches, bioresorbable stents, integration of ai and machine learning, cross-specialty collaboration.

Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/bifurcation-lesions-global-market-report

The Business Research Company's reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Market Drivers - The increase in geriatric population is expected to drive the growth of the bifurcation lesions market. People whose age is more than 60 years are more likely to suffer a heart attack, a stroke, or develop coronary heart disease and heart failure than younger people. In such cases, bifurcation lesions help treat the blood clots to allow adequate blood flow to your heart. For instance, in October 2022, according to a report published by the World Health Organization (WHO), a Switzerland-based agency responsible for international public health, one in six people is expected to be 60 or older by the year 2030, in the entire world. By 2050, there will be 2.1 billion people worldwide who are 60 years old or older. The number of persons who are 80 years of age or older will increase by 426 million between 2020 and 2050 compared to the current population. Therefore, the increasing geriatric population will drive the bifurcation lesions market growth.

The bifurcation lesions market covered in this report is segmented –

1) By Types: One-Stent, Two-Stent 2) By Application: Coronary Vascular, Peripheral Vascular

Get an inside scoop of the bifurcation lesions market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=7414&type=smp

Regional Insights - North America was the largest region in the bifurcation lesions market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bifurcation lesions market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Key Companies - Major companies operating in the bifurcation lesions market include Boston Scientific Corporation, Terumo Medical Corporation, Spectranetics Corporation, Medtronic plc, Cardinal Health Inc., Cardinal Health Company, Abbott Laboratories, Biosensors International Group Ltd., B. Braun Melsungen AG, Cook Medical LLC, Cordis Corporation, Endologix Inc., W. L. Gore & Associates Inc., InspireMD Inc., Lombard Medical Technologies PLC, MicroPort Scientific Corporation, OrbusNeich Medical Company Limited, Biotronik SE & Co. KG, Cardionovum GmbH, Elixir Medical Corporation, Medinol Ltd., Meril Life Sciences Pvt. Ltd., MIV Therapeutics Inc., Natec Medical Ltd., Opto Circuits (India) Ltd., QualiMed Innovative Medizinprodukte GmbH, Sahajanand Medical Technologies Pvt. Ltd., Svelte Medical Systems Inc., Translumina GmbH, Vascular Concepts Limited, Vascular Solutions Inc., Veryan Medical Ltd., X-Cell Medical Inc., Zorion Medical Inc., Amaranth Medical Inc., Cardiomind Inc., Cardiva Medical Inc.

Table of Contents 1. Executive Summary 2. Bifurcation Lesions Market Report Structure 3. Bifurcation Lesions Market Trends And Strategies 4. Bifurcation Lesions Market – Macro Economic Scenario 5. Bifurcation Lesions Market Size And Growth ….. 27. Bifurcation Lesions Market Competitor Landscape And Company Profiles 28. Key Mergers And Acquisitions 29. Future Outlook and Potential Analysis 30. Appendix

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[tamanna31]

Coronary Stents Market Key Vendors, Manufacturers, Suppliers and Analysis Industry Report 2030

Coronary Stents Industry Overview

The global coronary stents market size was estimated at USD 9.32 billion in 2022 and is expected to grow a compound annual growth rate (CAGR) of 3.1% from 2023 to 2030.

Growing aging population and a rising prevalence of noncommunicable diseases such as cardiovascular diseases (CVDs), complex lesions, diabetes, obesity, and others are expected to drive demand for coronary stents over the forecast period. According to the World Health Organization (WHO), in 2019, CVDs were among the major causes of mortality worldwide of which ischemic heart disease (IHD) ranks as the most prevalent. In 2019, an estimated 17.9 million people died from CVDs, responsible for 32% of worldwide mortalities.

Gather more insights about the market drivers, restrains and growth of the Coronary Stents Market

According to research published by the National Library of Medicine in June 2021, one of the CVDs, coronary artery disease (CAD), causes roughly 6,10,000 fatalities yearly (an estimated 1 in 4 deaths) and is the major cause of mortality in the U.S. As a result, the unprecedented rise in CAD incidence is predicted to boost demand for an effective coronary stent device for treatment. This factor is expected to bolster the demand throughout the forecast period. Since a coronary stent is used in most of the Percutaneous Coronary Intervention (PCI) procedures.

The rising preference for minimally invasive surgeries (MIS) is another factor expected to boost the adoption of coronary stents over the forecast period. The advantages of these procedures include small incision wounds leading to higher patient satisfaction. These procedures also provide shorter hospital stays and facilitate quick recovery. Stenting technology is increasingly preferred over the conventional balloon angioplasty owing to the introduction of advanced DES and evolving bioresorbable scaffolds. Technological advancements in coronary stents, such as the development of bifurcated stents and the use of biodegradable materials, have led to efficient and improved outcomes of CVD treatment. Companies are proactively involved in product developments and partnerships and strategic collaborations. The aforementioned factors are expected to propel market growth over the forecast period.

The impact of COVID-19 on the market for coronary stents closely tracked the impact of COVID-19 on overall PCI procedures. During the pandemic's initial outbreak and periods of high local COVID-19 case counts, several states, towns, and nations issued orders to citizens to shelter in place or minimize the potential exposure to and transmission of illness, resulting in elective surgeries being postponed. As a result, total PCI procedure volumes-and hence coronary stent unit sales and revenues-went significantly lower in 2020. These revenues are expected to rise as facility capacity usage improves and resumes all the semi-elective to non-urgent procedures.

The notable competitors in the market for coronary stents announced revenue falls in their interventional cardiology portfolios, which include coronary stent devices, in 2020, due to the impact of the COVID-19 pandemic. Boston Scientific, for instance, reported a significant decrease in annual revenues in its Interventional Cardiology segment, which includes coronary stent devices, in 2020, but the company performed relatively well in the first quarter of 2021, reporting revenue growth of approximately 7% globally compared to the first quarter of 2020. In contrast, Abbott Laboratories Laboratories was the least affected, with less impact on its entire vascular segment in 2020, which includes coronary stent devices, in its 2020 annual results.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global disposable hospital gowns market size was valued at USD 3.68 billion in 2023 and is projected to grow at a CAGR of 12.9% from 2024 to 2030.

• The global knee braces market size was valued at USD 1.12 billion in 2023 and is projected to grow at a CAGR of 7.7% from 2024 to 2030.

Competitive Insights

Product launches, approvals, strategic acquisitions, and innovations are some of the crucial business strategies adopted by market participants to maintain and grow their global reach. Abbott Laboratories, Boston Scientific, and Medtronic accounted for a significant presence in the overall market. These companies have gained a notable presence in the market due to good strong performances in the lucrative DES market and large product portfolios spanning numerous different IC device categories. For instance, in August 2022, Medtronic launched the Onyx Frontier drug-eluting stent (DES). The new product offers advanced delivery management and improves the overall performance in the most challenging cases.

Despite the dominance of the three major manufacturers, the market for coronary stents is a blend of numerous global and local players. BIOTRONIK, for instance, has been able to establish a significant presence in the entire market by offering low pricing and new technologies that address unmet needs. Positive clinical results from BIOTRONIK's BIONYX, BIOFLOW-V, and BIOSOLVE trials, in conjunction with the use of BIOTRONIK's Orsiro DES and Magmaris BRS, have positioned the company well to compete against the market's largest players. BIOTRONIK is also one of the most competitive players in the overall BRS device market. Terumo Corporation, Biosensors International, and Cardinal Health are a few additional significant competitors in this market. Some of the prominent players in the global coronary stents market include:

Abbott

Medtronic

Boston Scientific Corporation

Terumo Corporation

B Braun Melsungen AG

Biotronik

Stentys SA

MicroPort Scientific Corporation

C. R. Bard, Inc.

Cook Medical

Order a free sample PDF of the Coronary Stents Market Intelligence Study, published by Grand View Research.

[adityarana1687-blog]

Coronary Stents Market Size To Reach $12.10 Billion By 2030

The global coronary stents market size is expected to reach USD 12.10 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.1% from 2023 to 2030. Increasing adoption of minimally invasive surgeries and Percutaneous Coronary Intervention (PCI) procedures is expected to drive the market in the coming years. For instance, according to The Korean Journal of Thoracic and Cardiovascular Surgery, the proportion of PCI for Coronary Artery Disease (CAD) was 78% in 2016, and the country-specific PCI proportion was 96%, which was significantly higher than the global average. As a result, the unprecedented growth in CAD incidence, along with an increase in the proportion of PCIs done in these CAD patients, is expected to raise demand for an effective coronary stent technology. 

Technological advancement and the launch of 2nd generation drug-eluting stents are further fueling the growth. For instance, Abbott Laboratories Laboratories' XIENCE Sierra became the first DES approved for CTO indications in the US in May 2018. Medtronic followed suit in early 2019, obtaining FDA approval for the use of its Resolute range of DES in CTO indications. In addition, many companies have recently launched newer versions of their coronary stent systems in the US, notably Boston Scientific's Synergy Megatron in January 2021 and Abbott Laboratories Laboratories' XIENCE Skypoint in June 2021. 

The global COVID-19 pandemic has had a negative impact on the market for coronary stents. According to guidelines from physician societies throughout the world, procedure deferrals primarily impacted less urgent or elective procedures for eligible patients. ACC's ((American College of Cardiology) 2020 guidance, for instance, recommended postponing non-urgent procedures like CTO interventions and surveillance angiography during the peak of the COVID-19 pandemic. These guidelines have influenced physicians' treatment decisions throughout the world. Additionally, according to the European Society of Cardiology recommendations, all emergency and urgent PCI procedures (treatment of STEMI, high or intermediate risk NSTEMI, cardiogenic shock, and unstable angina) should be continued during the peak of the pandemic and in the subsequent resurgence of COVID-19, while only elective PCI procedures (CTO interventions or treatment of NYHA II symptoms) should be deferred.

Moreover, recovery of the coronary stent market from the COVID-19 pandemic is anticipated to be aided by the continuous performance of urgent PCI procedures and an increase in capacity utilization for performing non-elective procedures.

The coronary stent market is driven by reimbursement coverage provided by the general public Center for Medicare & Medicaid Services (CMS) and private payers. The coverage is availed under national coverage determination for carotid artery stenting, including products and service providers. From January 2020, the Centers for Medicare & Medicaid Services (CMS) proposed reimbursement for some angioplasty and stenting procedures performed in the ambulatory surgical centers (ASC), which is expected to boost the market revenue over the forecast period. 

Request a free sample copy or view the report summary: Coronary Stents Market Report

Coronary Stents Market Report Highlights

Overall PCI procedure volumes treated with coronary stent devices will rise as the aging population and the PCI-eligible patient population grows, owing to new technologies and increased ability to treat severe lesions

The bioresorbable vascular scaffold segment is expected to be the second fastest growing segment due to its several advantages in treating coronary artery disease including temporary placement in the patient heart, ease for future treatments as it degrades over 3 years, and it dissolve completely in the patient body.

Favorable clinical trials have demonstrated that DES is better than standard BMS. As a result, in 2021, DES has dominated the market

North America dominated the coronary stents market and accounted for the largest revenue share of 32.6% in 2022 and is anticipated to witness the same trend over the foreseeable future.

The Asia Pacific market for coronary stents is expected to exhibit the fastest growth rate in terms of revenue generation. This market is driven by some additional variables of enhanced screening for CAD, economic growth, regulatory updates, and notable beneficial reimbursement in some countries such as Australia and South Korea.

Coronary Stents Market Segmentation

Grand View Research has segmented the global coronary stents market based on product, and region:

Coronary Stents Product Outlook (Revenue, USD Million, 2018 - 2030)

Bare Metal Stents (BMS)

Drug-Eluting Stents (DES)

Biodegradable

Non-Biodegradable

Bioresorbable Vascular Scaffold

Coronary Stents Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

U.S.

Canada

Europe

UK

Germany

France

Italy

Spain

Sweden

Norway

Denmark

Asia Pacific

Japan

China

India

Australia

Thailand

South Korea

Latin America

Brazil

Mexico

Argentina

Middle East and Africa

Saudi Arabia

South Africa

UAE

Kuwait

List of Key Players of Coronary Stents Market

Abbott

Medtronic

Boston Scientific Corporation

Terumo Corporation

B Braun Melsungen AG

Biotronik

Stentys SA

MicroPort Scientific Corporation

C. R. Bard, Inc.

Cook Medical

[blueweave]

 India Cardiovascular Devices Market size by value at USD 0.91 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects India Cardiovascular Devices Market size to expand at a CAGR of 9.15% reaching a value of USD 1.67 billion by 2030. The Cardiovascular Devices Market in India is propelled by the escalating burden of heart failures, exacerbated by the COVID-19 pandemic. Initiatives like the National Heart Failure Biobank are playing a pivotal role in accelerating market growth by fostering research and enhancing treatment capabilities. Technological advancements, such as AI, robotics, and innovative product launches like Medtronic's Micra AV and Arctic Front, are also contributing significantly. The increasing prevalence of cardiovascular diseases among India's aging population further underscores the market's potential. As healthcare infrastructure continues to improve and awareness campaigns gain momentum, India Cardiovascular Devices Market is well-positioned to maintain a strong and steady growth trajectory.

Opportunity - Technological Advancements to Enhance Patient Care and Reduce Costs

Advancements in technology have significantly improved patient care and reduced costs in India Cardiovascular Devices Market. Innovations such as drug-eluting stents and bioresorbable alternatives enhance treatment outcomes, while cutting-edge catheterization techniques like intravascular ultrasound (IVUS) and optical coherence tomography (OCT) provide precise coronary artery imaging for better diagnosis and treatment. The rise of robotic-assisted and minimally invasive procedures reduces recovery times and complications, offering patients quicker, less painful recoveries with fewer risks. Advanced imaging technologies, including cardiac MRI and 3D echocardiography, enable accurate diagnosis and treatment planning, while implantable devices like pacemakers and defibrillators with remote monitoring capabilities efficiently manage heart rhythm disorders. Artificial intelligence (AI) and machine learning (ML) facilitate early detection and personalized treatment plans, and telemedicine enables remote consultations, broadening access, especially in underserved areas. Wearable devices and mobile apps enhance remote cardiac monitoring and rehabilitation, while 3D printing, and nanotechnology contribute to patient-specific models and advanced drug delivery systems. These technological advancements not only improve diagnostic precision and treatment efficacy but also reduce the overall cost of care by minimizing hospital stays, complications, and post-operative care needs.

Sample Request @ https://www.blueweaveconsulting.com/report/india-cardiovascular-devices-market/report-sample

[pranalip]

Cardiovascular Devices Market – In Depth Insight Analysis to 2033 | Global Insight Services

“Global Insight Services offers unparalleled market intelligence and strategic consulting services to businesses worldwide. Our expertise spans across various industries, including healthcare, technology, and consumer goods, providing comprehensive analysis and actionable insights. By leveraging advanced data analytics and in-depth market research, we empower our clients to make informed decisions, identify growth opportunities, and stay ahead of the competition”.

The global cardiovascular devices market size was USD 53.3 billion in 2021 and is anticipated to reach USD 91.9 billion in 2031, growing at a rate of 5.2% from 2022 to 2031.

Cardiovascular diseases (CVDs) are a group of disorders of the heart and blood vessels and include coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other conditions. Cardiovascular devices such as stents, catheters, grafts, and others are used to treat CVDs efficiently.

View The Full Report Here –https://www.globalinsightservices.com/reports/cardiovascular-devices-market

Market Trends and Drivers

The cardiovascular devices control irregularities caused by the heart’s electrical systems, such as irregular heartbeat and heart rhythm disorders. When medication, lifestyle changes, or other treatments do not work, an implantable device may be recommended. Certain factors that are boosting the cardiovascular devices market growth include a rise in the use of ambulatory and home services for cardiac monitoring, the increasing prevalence of cardiovascular disorders, favorable reimbursement policies, and technological advancements.

Besides, the growth of the global cardiovascular devices market is also attributed to the growing demand for high-performance and efficient cardiovascular systems globally. Increasing awareness regarding the benefits of the cardiovascular devices market is expected to positively impact the revenue growth of the market over the forecast period. In addition, developments in cardiovascular devices positively contribute to the growth of the global cardiovascular devices market. Further, the rising demand for cardiovascular devices from emerging economies to treat patients suffering from cardiovascular devices effectively is expected to cater to the growth of the cardiovascular devices industry. Besides, the rise in the number of hospitals in addition to small and medium-sized companies is increasing the demand for cardiovascular devices. Furthermore, technological advancements in cardiovascular devices are anticipated to offer lucrative opportunities for the market players.

Market Restraints & Challenges

One of the major factors hindering the global cardiovascular devices market growth is the stringent regulatory requirements that delay the approval of cardiac devices. In addition, the other concern & risk connected to the market is that the therapeutic radiation used in cancer treatment affects the operation of a patient with implantable cardiac rhythm devices. This device uses complementary metal-oxide-semiconductor (CMOS) which are susceptible to damage by the therapeutic doses of radiation. This factor is one of the major factors that limits the scope of using cardiac devices, as the implants are highly sensitive and their malfunctioning may have serious consequences. Besides, the high cost of these devices along with limited insurance coverage is restraining the growth of the market.

Unlock Growth Potential in Your Industry – Get Your Sample Report Now-https://www.globalinsightservices.com/request-sample/GIS20313

Market Segments

By Type

Diagnostic & Monitoring Devices

Therapeutic & Surgical Devices

By Application

Cardiac Rhythm Management & Heart Failure

Coronary Vascular

Structural Heart

Peripheral Vascular

Others

By End User

Hospitals

Specialty Centers

Major Players of the Global Cardiovascular devices Market

The global cardiovascular devices market report includes players such as Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corp., Cardinal Health Inc., Cook Medical, Koninklijke Philips N.V., Medtronic plc., and Terumo Corporation.

Prominent players in the industry such as Abbott Laboratories, Boston Scientific Corp., and Medtronic plc. are focusing on adopting acquisition as their key developmental strategy to boost the product offerings of cardiovascular devices. For instance, in February 2022, Boston Scientific acquired Baylis Medical Company Inc., which offers advanced transseptal access solutions along with guidewires, sheaths, and dilators used to support catheter-based left-heart procedures.

COVID-19 Analysis:

According to the International Monetary Fund (IMF), due to the epidemic of a novel coronavirus, the worldwide economy decreased by over 3.0% in 2020. Several nations were under strict lockdowns in 2020 & 2021, which have impacted the supply of raw materials. Therefore, due to this, the manufacturing activities of cardiovascular device producers have ceased. While some cardiovascular procedures are considered urgent, others have been postponed and delayed since the beginning of the global pandemic. The other aspect negatively affecting the market is the drop in the diagnosis of cardiovascular diseases owing to healthcare resources being reserved for COVID-19 patients. Besides, several medical device companies have suffered losses in their cardiovascular device businesses owing to the pandemic. To cite an instance, Medtronic plc announced a reduction of nearly one-third in its cardiac and vascular business sector in its 2020 quarterly financial results. Moreover, demand for cardiovascular devices from hospitals has been dropped amid their stopped operations, due to government-imposed lockdown measures. This is anticipated to hamper the cardiovascular devices market growth during the forecast period.

Buy Now@https://www.globalinsightservices.com/checkout/single_user/GIS20313

 Research Scope

Scope – Highlights, Trends, Insights. Attractiveness, Forecast

Market Sizing – Product Type, End User, Offering Type, Technology, Region, Country, Others

Market Dynamics – Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porters 5 Forces, Ansoff Analysis, Supply Chain

Business Framework – Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments

Competitive Landscape – Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis

Company Profiles – Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis.

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions

In-depth segmentation which can be customized as per your requirements

Free consultation with lead analyst of the report

Infographic excel data pack, easy to analyze big data

Robust and transparent research methodology

Unmatched data quality and after sales service

Contact Us:

Global Insight Services LLC 16192, Coastal Highway, Lewes DE 19958 E-mail: info@globalinsightservices.com Phone: +1-833-761-1700 Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

[pranalipawarshinde]

Cardiovascular Devices Market – Exclusive Report Study on the Current Trends And Forecast 2024-2033

“Global Insight Services offers unparalleled market intelligence and strategic consulting services to businesses worldwide. Our expertise spans across various industries, including healthcare, technology, and consumer goods, providing comprehensive analysis and actionable insights. By leveraging advanced data analytics and in-depth market research, we empower our clients to make informed decisions, identify growth opportunities, and stay ahead of the competition”.

The global cardiovascular devices market size was USD 53.3 billion in 2021 and is anticipated to reach USD 91.9 billion in 2031, growing at a rate of 5.2% from 2022 to 2031.

Cardiovascular diseases (CVDs) are a group of disorders of the heart and blood vessels and include coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other conditions. Cardiovascular devices such as stents, catheters, grafts, and others are used to treat CVDs efficiently.

View The Full Report Here –https://www.globalinsightservices.com/reports/cardiovascular-devices-market

Market Trends and Drivers

The cardiovascular devices control irregularities caused by the heart’s electrical systems, such as irregular heartbeat and heart rhythm disorders. When medication, lifestyle changes, or other treatments do not work, an implantable device may be recommended. Certain factors that are boosting the cardiovascular devices market growth include a rise in the use of ambulatory and home services for cardiac monitoring, the increasing prevalence of cardiovascular disorders, favorable reimbursement policies, and technological advancements.

Besides, the growth of the global cardiovascular devices market is also attributed to the growing demand for high-performance and efficient cardiovascular systems globally. Increasing awareness regarding the benefits of the cardiovascular devices market is expected to positively impact the revenue growth of the market over the forecast period. In addition, developments in cardiovascular devices positively contribute to the growth of the global cardiovascular devices market. Further, the rising demand for cardiovascular devices from emerging economies to treat patients suffering from cardiovascular devices effectively is expected to cater to the growth of the cardiovascular devices industry. Besides, the rise in the number of hospitals in addition to small and medium-sized companies is increasing the demand for cardiovascular devices. Furthermore, technological advancements in cardiovascular devices are anticipated to offer lucrative opportunities for the market players.

Market Restraints & Challenges

One of the major factors hindering the global cardiovascular devices market growth is the stringent regulatory requirements that delay the approval of cardiac devices. In addition, the other concern & risk connected to the market is that the therapeutic radiation used in cancer treatment affects the operation of a patient with implantable cardiac rhythm devices. This device uses complementary metal-oxide-semiconductor (CMOS) which are susceptible to damage by the therapeutic doses of radiation. This factor is one of the major factors that limits the scope of using cardiac devices, as the implants are highly sensitive and their malfunctioning may have serious consequences. Besides, the high cost of these devices along with limited insurance coverage is restraining the growth of the market.

Unlock Growth Potential in Your Industry – Get Your Sample Report Now-https://www.globalinsightservices.com/request-sample/GIS20313

Market Segments

By Type

Diagnostic & Monitoring Devices

Therapeutic & Surgical Devices

By Application

Cardiac Rhythm Management & Heart Failure

Coronary Vascular

Structural Heart

Peripheral Vascular

Others

By End User

Hospitals

Specialty Centers

Major Players of the Global Cardiovascular devices Market

The global cardiovascular devices market report includes players such as Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corp., Cardinal Health Inc., Cook Medical, Koninklijke Philips N.V., Medtronic plc., and Terumo Corporation.

Prominent players in the industry such as Abbott Laboratories, Boston Scientific Corp., and Medtronic plc. are focusing on adopting acquisition as their key developmental strategy to boost the product offerings of cardiovascular devices. For instance, in February 2022, Boston Scientific acquired Baylis Medical Company Inc., which offers advanced transseptal access solutions along with guidewires, sheaths, and dilators used to support catheter-based left-heart procedures.

COVID-19 Analysis:

According to the International Monetary Fund (IMF), due to the epidemic of a novel coronavirus, the worldwide economy decreased by over 3.0% in 2020. Several nations were under strict lockdowns in 2020 & 2021, which have impacted the supply of raw materials. Therefore, due to this, the manufacturing activities of cardiovascular device producers have ceased. While some cardiovascular procedures are considered urgent, others have been postponed and delayed since the beginning of the global pandemic. The other aspect negatively affecting the market is the drop in the diagnosis of cardiovascular diseases owing to healthcare resources being reserved for COVID-19 patients. Besides, several medical device companies have suffered losses in their cardiovascular device businesses owing to the pandemic. To cite an instance, Medtronic plc announced a reduction of nearly one-third in its cardiac and vascular business sector in its 2020 quarterly financial results. Moreover, demand for cardiovascular devices from hospitals has been dropped amid their stopped operations, due to government-imposed lockdown measures. This is anticipated to hamper the cardiovascular devices market growth during the forecast period.

Buy Now@https://www.globalinsightservices.com/checkout/single_user/GIS20313

 Research Scope

Scope – Highlights, Trends, Insights. Attractiveness, Forecast

Market Sizing – Product Type, End User, Offering Type, Technology, Region, Country, Others

Market Dynamics – Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porters 5 Forces, Ansoff Analysis, Supply Chain

Business Framework – Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments

Competitive Landscape – Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis

Company Profiles – Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis.

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions

In-depth segmentation which can be customized as per your requirements

Free consultation with lead analyst of the report

Infographic excel data pack, easy to analyze big data

Robust and transparent research methodology

Unmatched data quality and after sales service

Contact Us:

Global Insight Services LLC 16192, Coastal Highway, Lewes DE 19958 E-mail: info@globalinsightservices.com Phone: +1-833-761-1700 Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

[themarketupdate]

Coronary Stents Market Will Hit Big Revenues In Future | Biggest Opportunity Of 2024

A coronary stent is referred to as a miniature tube which is been used to open a narrowed artery during the procedure of PCI (percutaneous coronary intervention). This kind of treatment comprises of the insertion of a balloon-tipped tube in the artery system which is then transported to the location of the blockage. The stent enlarges and after the balloon inflates it forms a platform. This procedure helps the artery to open and stabilize the flow of blood to the heart. The Coronary stents are basically used in the treatment of cardiac disorders like myocardial infarction, angina pain, and coronary artery disease. The market of the coronary stents is increasing due to the growing demand for procedures of minimally invasive surgical. While some of the factors like the risk associated with the surgery and technical issue regarding the stents can cause the hampering of the market.

Free Sample Report + All Related Graphs & Charts @: https://www.advancemarketanalytics.com/sample-report/50325-global-coronary-stents-market?utm_source=Organic&utm_medium=Vinay

Latest released the research study on Global Coronary Stents Market, offers a detailed overview of the factors influencing the global business scope. Coronary Stents Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Coronary Stents The study covers emerging player’s data, including: competitive landscape, sales, revenue and global market share of top manufacturers are Abbott Laboratories (United States), Boston Scientific Corporation (United States), Elixir Medical Corporation (United States), Reva Medical Inc. (United States), C. R. Bard, Inc. (United States), Medtronic (United States), Proven Process Medical Devices, Inc. (United States), Edwards Lifesciences (United States), W. L. Gore & Associates (United States)

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Southeast Asia.

Contact Us:

Craig Francis (PR & Marketing Manager)

AMA Research & Media LLP

Unit No. 429, Parsonage Road Edison, NJ

New Jersey USA – 08837

sales@advancemarketanalytics.com

[wellnessweb]

Predictions for Coronary Stent Market Size by 2025

The Coronary Stent Market size was valued at USD 9.63 Billion In 2023 & is estimated to reach USD 12.49 Billion by 2031 and increase at a compound annual growth rate of 3.3% between 2024 and 2031.The coronary stent market, a pivotal sector within cardiovascular healthcare, continues to evolve rapidly, driven by advancements in technology, rising prevalence of coronary artery diseases (CAD), and increasing adoption of minimally invasive procedures globally. These tiny mesh-like tubes, designed to restore blood flow in narrowed or blocked arteries, represent a critical innovation in modern cardiology, offering patients a less invasive alternative to traditional open-heart surgery. The market is characterized by a diverse array of stent types, including bare-metal stents (BMS), drug-eluting stents (DES), and bioresorbable stents, each catering to specific clinical needs and patient profiles.

Innovations in stent materials, coatings, and deployment techniques have significantly enhanced efficacy and safety, reducing the risk of restenosis and thrombosis. Geographically, North America and Europe have traditionally led in market share, supported by robust healthcare infrastructure and high adoption rates of advanced medical technologies. However, emerging economies in Asia-Pacific and Latin America are rapidly expanding due to improving healthcare access and increasing awareness among both healthcare providers and patients. Regulatory advancements and clinical research continue to drive product development and market growth, ensuring that coronary stents remain at the forefront of cardiovascular care, providing critical support to millions of patients worldwide.

Get Sample Of This Report @ https://www.snsinsider.com/sample-request/3437

The Coronary Stent Market  report contains in-depth analyses of the value chain and market distributors. The market analysis also covers a number of crucial factors that have a big impact on market growth. The report also includes a statistical analysis that identifies and lists the numerous market-influencing and market-restraining variables. With the use of market scenarios, the research report's scope is broadened to include a comparison of the top service providers, their profits, and the prices of significant market segments.

COVID-19 Impact Analysis

Fewer items have been shipped globally overall as a result of the corona virus outbreak. The raw material supply, which is essential for the sector's sustainability, has also been impacted by this. This study on the Coronary Stent Market offers a thorough analysis of market shipping production throughout the course of the forecast period, together with observations of noteworthy changes over time.

Market Segmentation

By Type

Bioabsorbable Stents

Bare-metal Coronary Stents

Drug-eluting Stents

By Biomaterial

Natural biomaterials

Polymers biomaterials

Metallic biomaterials

By End Users

Ambulatory Surgical Centers

Hospitals

Other

Regional Analysis

The Coronary Stent Market research examines and analyses every segment of the regional market in terms of its key regional market reach. The report covers import, export, development, demand, and consumption in great depth. The research covers in-depth the major international regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa.

Competitive Outlook

The research provided a succinct summary of the major contributors and market participants in order to respond to various questions from customers and readers. Customers will also learn about crucial factors in this study that, in terms of the supplier environment and present competition intensity, have a substantial impact on the development of the Coronary Stent Market. The in-depth analysis of manufacturers, producers, distributors, and traders in the report is meant to assist key players with a variety of strategic choices and investment goals. Secondary and verified primary sources are used to analyse production data, percentage splits, market shares, product industry breakdowns, and growth rates for important competitors.

Key Objectives of Coronary Stent Market  Report

You can more clearly evaluate the potential of the major markets by having a thorough understanding of the specific market size and forecast information.

Conducting a detailed market analysis with an emphasis on market expansion and examining how current market developments have impacted customers' purchasing patterns.

About Us

SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in reframing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.

When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.

Related Reports

Hyperphosphatemia Treatment Market Trends

Hypoparathyroidism Treatment Market Trends

Image guided Biopsy Market Trends

Immunohistochemistry Market Trends

Immunology Market Trends

[researchinsightstopics]

Medical Plastics Market Scope, Size, Share, Trends, Forecast By 2031

The circumstantial development of plastics used in the medical industry has led to several technological advancements in recent years. The expansion of comprehensive medical care facilities in developed nations across all socio-economic boundaries, combined with the penetration of modern medical care techniques in developing regions, has significantly bolstered the market for medical devices and their packaging. The associated cost and safety concerns have prompted a growing potential market for plastic medical products. At present, plastics reign supreme in the medical world with numerous applications, including tubing, containers for IV and dialysis fluids, blood bags, dialysis bags, IV sets, and examination and surgical gloves.

For Full Industry Insights: https://www.fairfieldmarketresearch.com/report/medical-plastics-market

Polycarbonate and PEEK Outweighing Conventional Plastics’ Demand

Depending on customer requirements, cost-effectiveness, raw material availability, and applicability, medical device manufacturers opt for different types of plastics. Conventional plastics such as PVC, PP, and PE account for more than 30% share in the medical industry. However, with the emergence of high-temperature applications of plastics, device manufacturers are shifting focus towards advanced polymers such as engineering thermoplastics, which are used for various stages of disease management and surgeries.

The advanced polymers increasingly finding space in the medical industry include polycarbonate, acetal copolymer, polymethyl methacrylate, polyether ether ketone, and polyphenylsulfone, among others. The unique set of characteristics of plastics has enabled manufacturers in the medical plastics market to replace titanium/stainless steel metals with plastics in medical tubing applications. Examples of medical devices made using plastics include surgical instruments, catheters, coronary stents, pacemakers, MRI machines, X-ray machines, prosthetic limbs, artificial hips/knees, surgical gloves, and bandages.

Robust Development in Implantable Devices Arising Need for Engineered Polymers

Biocompatibility and durability are considered the most important factors when selecting a new raw material for any medical product. It requires a tremendous amount of research to select apt polymers to replace metal usage in medical devices. This factor has led to exceptional developments of implantable devices, giving rise to the demand for suitable polymers.

In the 1990s, many suppliers were resistant to serve the medical industry due to high regulatory requirements, small volume consumption, and high-profile litigations. Those who did supply this market charged higher costs associated with regulatory compliance and risk management. To overcome such challenges, polymer manufacturers are continuously making efforts toward product innovations, focusing on biocompatibility, while others are developing combination products with drugs blended into polymers.

Plastics have contributed immensely to the healthcare sector during the pandemic, enabling public safety. Frequent usage of hand sanitizers along with wearing plastic-based personal protective equipment (PPE), including face masks, gloves, medical suits, aprons, gowns, face shields, surgical masks, and other PPEs, have proven to be the best possible solutions in these challenging times. Properties of plastic, such as an excellent strength-to-weight ratio and durability, along with versatility, have made plastics irreplaceable in the healthcare industry. Thus, medical plastics are likely to find major applications in single-use medical tools, equipment, and most importantly, packaging.

Regulatory Requirements Intensifying for Medical Devices

Regulatory requirements for medical devices have been progressively becoming more stringent over the past few years. Examples include tighter material specifications for medical applications, USP and ISO-10993 testing compliance, and no-change policies for manufacturing or formulations. In most cases, these compliances and tests are levied upon the raw polymer suppliers. This has made polymer suppliers more aware of the unique requirements of the medical market.

COVID-19 Reemphasizes the Role of Single-use Plastics in North America

In North America, the demand for blood bags to store blood and blood components has increased considerably over the past year. A double-digit increase in the demand for convalescent plasma as COVID-19 cases surged in numerous states has been observed since June 2020. As people become more aware and the number of blood donors constantly rises, the regional blood bag market is on the rise as well. Not only this, but the demand for intravenous (IV) bags and dialysis bags is also on the continuous rise, not just because of COVID-19 but also due to other health-related issues. The Centers for Disease Control and Prevention (CDC) is continuously updating its guidelines regarding the disposal of medical waste. This ensures a protocol-driven risk assessment and recommends mitigation steps to be adhered to by clinical and biomedical laboratories. Therefore, the demand for biohazard bags is expected to rise at a substantial pace worldwide in the near future. This has had a compelling effect on polymer manufacturers to utilize their production capacity to the maximum extent in order to fulfill this ever-increasing demand.

Asia Pacific and Europe, highly virus-affected regions, had to overutilize their production plants for manufacturing medical products and devices. This led to tremendous demand for raw materials, with plastic being the key amongst all. The role of plastics in these regions has been inevitable due to the tremendous demand from highly populated areas.

Companies Focusing on Capacity Expansion to Meet the Soaring Demand

The key companies operating in the global medical plastics market include Celanese Corporation, Eastman Chemical Company, GW Plastics, Orthoplastics Ltd, Aran Biomedical Teoranta, Rochling, SABIC, Saint-Gobain Performance Plastics, SOLVAY, and DOW Chemical Company. These leading market players are devising strategies such as partnerships, mergers and acquisitions, facility expansions, and research and development to expand their geographic presence and customer base worldwide.

In January 2020, GW Plastics completed the expansion of its Royalton, Vermont Manufacturing and Technology Center to expand its medical device business. To extend a helping hand in managing the current COVID-19 crisis, Solvay has promised to supply high-performance, medical-grade transparent film to Boeing for the production of face shields.

[spookysaladchaos]

Global Top 5 Companies Accounted for 83% of total Cardiac Stent market (QYResearch, 2021)

A Cardiac Stent (also called coronary stent) is a tube-shaped device placed in the coronary arteries that supply blood to the heart, to keep the arteries open in the treatment of coronary heart disease. It is used in a procedure called percutaneous coronary intervention (PCI).

According to the new market research report “Global Cardiac Stent Market Report 2023-2029”, published by QYResearch, the global Cardiac Stent market size is projected to reach USD 12.38 billion by 2029, at a CAGR of 6.9% during the forecast period.

Figure.   Global Cardiac Stent Market Size (US$ Million), 2018-2029

Figure.   Global Cardiac Stent Top 11 Players Ranking and Market Share（Based on data of 2021, Continually updated）

The global key manufacturers of Cardiac Stent include Abbott Vascular, Boston Scientific, Medtronic, Terumo (ESSEN) (ESSEN), Lepu Medical, MicroPort, Biosensors, B.Braun, Atrium Medical, Biotronik, etc. In 2020, the global top five players had a share approximately 83.0% in terms of revenue.

About QYResearch

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 16 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.

QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.

For more information, please contact the following e-mail address:

Email: global@qyresearch.com

Website: https://www.qyresearch.com

[bhushans]

Meeting the Needs of a Growing Population: The Evolving Global Cardiovascular Repair & Reconstruction Devices Market

The global cardiovascular repair and reconstruction devices market is anticipated to increase dramatically, reaching USD 25,122.3 million by 2033 from USD 8,241.1 million in 2023. The cardiovascular repair and reconstruction devices market is projected to increase at an effective compound annual growth rate (CAGR) of 11.8% between 2023 and 2033.

Cardiovascular reconstruction and repair devices can be used to treat a variety of cardiovascular illnesses, including heart valve problems, coronary artery disease, and congenital heart defects. The need for improved cardiovascular devices is predicted to skyrocket as the burden of cardiovascular illnesses rises globally due to aging populations, sedentary lifestyles, and increased prevalence of risk factors including diabetes and hypertension.

Enhance Research With a Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-14804

Key Players:

APPLE INC.

SONOVA

ABBOTT

SAMSUNG ELECTRONICS CO., LTD.

MEDTRONIC

ACTIVINSIGHTS LTD.

Recent Developments in the Cardiovascular Repair & Reconstruction Devices Industry:

Medtronic:

Introduction of the Next-Generation Transcatheter Heart Valve System, offering improved procedural outcomes and enhanced durability.

Collaboration with prominent research institutions to advance regenerative medicine therapies for cardiovascular repair.

Abbott Laboratories:

Launch of the MitraClip G4, a minimally invasive device for mitral valve repair, providing enhanced precision and patient outcomes.

Investment in research and development for bioresorbable stents, aiming to revolutionize the field of cardiovascular reconstruction.

Edwards Lifesciences:

Development of innovative technologies, such as the SAPIEN 3 Ultra transcatheter aortic valve, delivering enhanced performance and durability.

Strategic partnerships with leading healthcare providers to streamline the adoption of advanced cardiovascular repair devices.

Key segments:

By Product:

Valve repair devices

TAVR

TMVR

Vascular Grafts

Peripheral vascular grafts

Aortic Graft

Cardiovascular Patches

By End User:

Hospitals

Independent Cardiac Catheterization Labs

Ambulatory Surgical Centers

By Region:

North America

Latin America

Europe

Asia Pacific

Middle East & Africa